Skip to the page

Data / Form D filings / Cour Pharmaceuticals Development Co Inc

Cour Pharmaceuticals Development Co Inc: Form D filings

Cour Pharmaceuticals Development Co Inc, a biotechnology company in Northbrook, IL, filed 4 Form D notices with the SEC between 2013 and 2016. The latest, on January 8, 2016, reports $169,251 sold of a $169,251 offering to 2 investors.

Find out what Cour Pharmaceuticals Development Co Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2215 Sanders Road, Suite 425, Northbrook, IL, 60062
Phone
(630) 833-3254
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2012
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1568153

The full lists. Form D filings in Illinois: 1,511 rows, $75.55, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 8, 2016New notice$169,251$169,251$02Dec 31, 2015sec.gov
Aug 28, 2014New notice$500,000$500,000$01Aug 25, 2014sec.gov
Apr 23, 2013New notice$16,977$16,977$01Apr 19, 2013sec.gov
Feb 6, 2013New notice$33,954$16,977$16,9771Jan 28, 2013sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
John J. PuisisExecutive Officer, Director
James J. HerrmannExecutive Officer, Director
Catherine J. MackeyDirector

Other biotechnology companies in Illinois that filed recently

Every Form D from the week of Jan 4, 2016 · All recent filings in Illinois · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Cour Pharmaceuticals Development Co Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.